Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-02-01 | Arbutus Biopharma Corp | Naftzger J. Chris...
(General Counsel and CCO) |
A | Common Shares | A | 95100 | $0.00 - $0.00 | $0 |
| 2024-02-02 | Arbutus Biopharma Corp | Sims Karen
(Chief Medical Officer) |
S | Common Shares | D | 4358 | $2.31 - $2.31 | $10,077 |
| 2024-02-01 | Arbutus Biopharma Corp | Sims Karen
(Chief Medical Officer) |
A | Common Shares | A | 101000 | $0.00 - $0.00 | $0 |
| 2024-02-02 | Arbutus Biopharma Corp | HASTINGS DAVID C
(Chief Financial Officer) |
S | Common Shares | D | 9593 | $2.31 - $2.31 | $22,183 |
| 2024-02-01 | Arbutus Biopharma Corp | HASTINGS DAVID C
(Chief Financial Officer) |
A | Common Shares | A | 112500 | $0.00 - $0.00 | $0 |
| 2024-02-02 | Arbutus Biopharma Corp | Sofia Michael J.
(Chief Scientific Officer) |
S | Common Shares | D | 9982 | $2.31 - $2.31 | $23,083 |
| 2024-02-01 | Arbutus Biopharma Corp | Sofia Michael J.
(Chief Scientific Officer) |
A | Common Shares | A | 109500 | $0.00 - $0.00 | $0 |
| 2024-02-02 | Arbutus Biopharma Corp | McElhaugh Michael J.
(Interim President & CEO) |
S | Common Shares | D | 10164 | $2.31 - $2.31 | $23,504 |
| 2024-02-01 | Arbutus Biopharma Corp | McElhaugh Michael J.
(Interim President & CEO) |
A | Common Shares | A | 123800 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |